The USFDA has issued an Establishment Inspection Report (EIR) for the manufacturing facility of Marksans Pharma located at Verna Industrial estate, Verna, Goa, India. The inspection has now been successfully closed by the USFDA. USFDA has determined that the inspection classification of this facility is Voluntary Action Indicated (VAI). The inspection was conducted by the USFDA at the manufacturing facility of the Company from April 09, 2024 to April 17, 2024.
Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.
